Inderes delivered Q4 sales slightly above our estimate while EBITA was broadly in line. Our pre-report 2023 estimates looks to be broadly in line with the fresh guidance with the note that we input a relatively hefty improvement in profitability. Looking ahead, we flag that the number of commissioned research contracts continues to top our estimate and Inderes is recruiting new analysts in Sweden, which we read as a positive sign. Overall, a neutral reaction seems justified.